Pfizer First: Oral Antiviral Paxlovid Wins EUA As Merck’s COVID Pill Languishes At US FDA

 
• By Sue Sutter
Crossing finish line
Pfizer beat Merck & Co./Ridgeback to the EUA finish line for COVID-19 oral antiviral treatments. • Source: Alamy

More from Review Pathways

More from Pathways & Standards